BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Treatment
476 results:

  • 1. CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma.
    Cheng K; Zhou Z; Chen Q; Chen Z; Cai Y; Cai H; Wu S; Gao P; Cai Y; Zhou J; Wang X; Wu Z; Peng B
    Sci Rep; 2024 Apr; 14(1):8389. PubMed ID: 38600093
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tyrosine phosphatase
    Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
    Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ACA-28, an erk MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and pancreatic cancer Cells.
    Takasaki T; Hamabe Y; Touchi K; Khandakar GI; Ueda T; Okada H; Sakai K; Nishio K; Tanabe G; Sugiura R
    Oxid Med Cell Longev; 2024; 2024():7683793. PubMed ID: 38500550
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lactate enhances NMNAT1 lactylation to sustain nuclear NAD
    Huang H; Wang S; Xia H; Zhao X; Chen K; Jin G; Zhou S; Lu Z; Chen T; Yu H; Zheng X; Huang H; Lan L
    Cancer Lett; 2024 Apr; 588():216806. PubMed ID: 38467179
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Glycolysis-non-canonical glutamine dual-metabolism regulation nanodrug enhanced the phototherapy effect for pancreatic ductal adenocarcinoma treatment.
    Qiao J; Liu S; Huang Y; Zhu X; Xue C; Wang Y; Xiong H; Yao J
    J Colloid Interface Sci; 2024 Jul; 665():477-490. PubMed ID: 38429120
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A case of esophageal squamous cell carcinoma accompanied by pancreatic and bile duct metastases: Successful treatment starts with an accurate diagnosis.
    Ito Y; Ikura Y; Sawai H; Osuga T
    J Cancer Res Ther; 2023 Oct; 19(7):2060-2063. PubMed ID: 38376319
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.
    Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H
    Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. PW06 suppresses cancer cell metastasis in human pancreatic carcinoma MIA PaCa-2 cells via the inhibitions of p-Akt/mTOR/NF-κB and MMP2/MMP9 signaling pathways in vitro.
    Huang YP; Yeh CA; Ma YS; Chen PY; Lai KC; Lien JC; Hsieh WT
    Environ Toxicol; 2024 May; 39(5):2768-2781. PubMed ID: 38264921
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. DON of Hope: Starving pancreatic cancer by Glutamine Antagonism.
    Pillai R; Papagiannakopoulous T
    Cancer Res; 2024 Feb; 84(3):349-350. PubMed ID: 38117482
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Blockade of DDR1/PYK2/erk signaling suggesting SH2 superbinder as a novel autophagy inhibitor for pancreatic cancer.
    Xu H; Tan M; Hou GQ; Sang YZ; Lin L; Gan XC; Cao X; Liu AD
    Cell Death Dis; 2023 Dec; 14(12):811. PubMed ID: 38071340
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma.
    Man KF; Zhou L; Yu H; Lam KH; Cheng W; Yu J; Lee TK; Yun JP; Guan XY; Liu M; Ma S
    Nat Commun; 2023 Nov; 14(1):7863. PubMed ID: 38030644
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy.
    Montenegro MF; Martí-Díaz R; Navarro A; Tolivia J; Sánchez-Del-Campo L; Cabezas-Herrera J; Rodríguez-López JN
    Cell Death Dis; 2023 Nov; 14(11):761. PubMed ID: 37996408
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeting ribosome biogenesis reinforces erk-dependent senescence in pancreatic cancer.
    Rowell MC; Deschênes-Simard X; Lopes-Paciencia S; Le Calvé B; Kalegari P; Mignacca L; Fernandez-Ruiz A; Guillon J; Lessard F; Bourdeau V; Igelmann S; Duman AM; Stanom Y; Kottakis F; Deshpande V; Krizhanovsky V; Bardeesy N; Ferbeyre G
    Cell Cycle; 2023 Oct; 22(19):2172-2193. PubMed ID: 37942963
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors.
    Beyer GV; Hueser S; Li R; Manika D; Lee M; Chan CHF; Howe JR; Ear PH
    Surgery; 2024 Mar; 175(3):605-612. PubMed ID: 37914572
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Apoptotic Effect of Gallic Acid via Regulation of p-p38 and ER Stress in PANC-1 and MIA PaCa-2 Cells pancreatic cancer Cells.
    Kim JW; Choi J; Park MN; Kim B
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894916
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis.
    Song N; Tang Y; Wang Y; Guan X; Yu W; Jiang T; Lu L; Gu Y
    Mar Drugs; 2023 Sep; 21(10):. PubMed ID: 37888452
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Hypoxia-induced circ-CDYL-EEF1A2 transcriptional complex drives lung metastasis of cancer stem cells from hepatocellular carcinoma.
    Kong R; Wei W; Man Q; Chen L; Jia Y; Zhang H; Liu Z; Cheng K; Mao C; Liu S
    Cancer Lett; 2023 Dec; 578():216442. PubMed ID: 37852428
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer.
    Briseño-Díaz P; Schnoor M; Bello-Ramirez M; Correa-Basurto J; Rojo-Domínguez A; Arregui L; Vega L; Núñez-González E; Palau-Hernández LA; Parra-Torres CG; García Córdova OM; Zepeda-Castilla E; Torices-Escalante E; Domínguez-Camacho L; Xoconostle-Cazares B; Meraz-Ríos MA; Delfín-Azuara S; Carrión-Estrada DA; Villegas-Sepúlveda N; Hernández-Rivas R; Thompson-Bonilla MDR; Vargas M
    Life Sci Alliance; 2023 Dec; 6(12):. PubMed ID: 37813486
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism.
    Encarnación-Rosado J; Sohn ASW; Biancur DE; Lin EY; Osorio-Vasquez V; Rodrick T; González-Baerga D; Zhao E; Yokoyama Y; Simeone DM; Jones DR; Parker SJ; Wild R; Kimmelman AC
    Nat Cancer; 2024 Jan; 5(1):85-99. PubMed ID: 37814010
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma.
    Karatug Kacar A
    Chem Biol Drug Des; 2024 Jan; 103(1):e14368. PubMed ID: 37802653
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 24.